Calcium Carbonate Patents (Class 424/687)
-
Patent number: 6692775Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: June 24, 2002Date of Patent: February 17, 2004Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Publication number: 20040028748Abstract: By obtaining a material usable in treating dermatophytosis from scallop shell, remedies for dermatophytosis which are harmless to the human body are prepared from natural materials while efficiently utilizing waste matters. Namely, remedies for dermatophytosis are obtained from a product formed by grinding shells having a crystalline structure due to the calcite structure of calcium carbonate.Type: ApplicationFiled: October 6, 2003Publication date: February 12, 2004Inventor: Koji Sasaya
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6682762Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.Type: GrantFiled: October 9, 2001Date of Patent: January 27, 2004Assignee: Heart-O-Dixie Animal Nutrition, LLCInventor: Martin Kenneth Register
-
Patent number: 6669928Abstract: The present invention provides a periodontal composition compounded to include at least one alkaline agent to render a gel or paste having a pH of at least 9.0 to 11.0, and preferably 9.5 to 10.0. The preferred alkaline agent included in the composition is potassium hydroxide, and the composition preferably also includes aluminum hydroxide, calcium carbonate and magnesium carbonate. Of these agents, potassium hydroxide is the most basic compound utilized.Type: GrantFiled: October 31, 2002Date of Patent: December 30, 2003Assignee: TAMER International, Ltd.Inventor: Ismail Macit Gurol
-
Publication number: 20030235613Abstract: Disclosed are popping pharmaceutical oral administration forms, which comprise an active ingredient, and pressurized gas trapped within cavities in a pharmaceutically acceptable material in a manner that allows the gas to escape from the administration form upon dissolution or shattering of said form.Type: ApplicationFiled: June 19, 2002Publication date: December 25, 2003Applicant: CTS Chemical Industries Ltd.Inventors: Sigal First, Rina Yamin
-
Publication number: 20030235628Abstract: Methods and pharmaceutical compositions for protecting pharmaceutical compounds (or drugs) in acidic environments are provided. Methods of treatment using formulations capable of protecting pharmaceutical compounds in acidic environments are also provided. Formulations provided generally comprise a therapeutically effective amount of at least one pharmaceutical compound, and a pharmaceutically acceptable protectant. The pharmaceutically acceptable protectant of the invention generally comprises a water-soluble acid neutralizer, and a water-insoluble acid neutralizer.Type: ApplicationFiled: September 19, 2001Publication date: December 25, 2003Inventors: Rajneesh Taneja, Pramod Gupta
-
Publication number: 20030232092Abstract: Liquid antacid preparations comprising: a) an active acid neutralizing compound selected from the group consisting of calcium-containing compounds, aluminum-containing compounds, magnesium-containing compounds, and mixtures thereof; and b) an antimicrobial adjuvant selected from the group consisting of propylene glycol in an amount greater than 2 weight percent and less than 15 weight percent, glycerin in an amount from about 15 to about 20 weight percent, and combinations of propylene glycol in an amount from about 3 to about 10 weight percent with glycerin in an amount from about 3 to about 10 weight percent based on the total weight of the preparation are provided.Type: ApplicationFiled: June 14, 2002Publication date: December 18, 2003Inventors: Donald L. Hasenmayer, John Case, Abbie Gentry, Indu G. Shah
-
Patent number: 6663892Abstract: A solid orally administrable pharmaceutical dosage form for the treatment of gastric disorders includes a first portion containing a therapeutically effective amount of a histamine H2-receptor antagonist, and a second portion immediately adjacent the first portion without an intervening barrier disposed between the first portion and the second portion, the second portion containing a therapeutically effective amount of an antacid. Physical separation of the active ingredients into two different portions without a separating barrier has been found sufficient to prevent degradation of the histamine H2-receptor antagonist due to contact with the antacid. The invention therefore provides stabilization of a histamine H2-receptor antagonist-antacid combination tablet which is comparable to known multiple portion tablets, but without an intervening barrier between the antacid portion and the histamine H2-receptor antagonist portion.Type: GrantFiled: August 19, 2002Date of Patent: December 16, 2003Assignee: L. Perrigo CompanyInventor: Deepak K. Thassu
-
Publication number: 20030219432Abstract: The invention provides a composition which is effective in the prevention or delay of the onset of side effects associated with alcohol consumption or the reduction or alleviation of those effects. The composition of the invention includes activated charcoal and limestone, optionally activated limestone. Optionally, the composition of the invention also includes vitamin B1 and/or other agents such as fatigue relieving agents. Preferably, the composition of the invention is provided in the form of tablets or powder encapsulated in a gelatin capsule. The composition of the invention is provided in pre-dosed quantities varying from between about 100 and 500 milligrams per dose. The invention also provides a method of reducing or alleviating the deleterious effects associated with alcohol consumption.Type: ApplicationFiled: March 13, 2003Publication date: November 27, 2003Inventors: Raymond C. Crippen, Manoj Bhargava, Thomas F. Morse
-
Publication number: 20030215525Abstract: The invention relates to heat stable liquid antacid and/or antigas preparations capable of being pasteurized in the temperature range of 60-100° C. comprising one or more acid neutralizing and/or antigas compounds in an aqueous liquid suspension consisting essentially of hydroxyethylcellulose as a suspending agent.Type: ApplicationFiled: November 26, 2002Publication date: November 20, 2003Inventors: Douglas S. Beyerle, John J. Dubek, Gerard P. McNally, Donald L. Hasenmayer, John Case, Abbie Gentry, Indu G. Shah
-
Publication number: 20030215526Abstract: A stable pharmaceutical composition comprising a) a therapeutically effective amount of an Angiotensin Converting Enzyme (“ACE”) inhibitor which is susceptible to degradation or its salt; b) a greater than stoichiometric amount of an alkali or alkaline earth metal carbonate, relative to the amount of ACE inhibitor or its salt; and c) a pharmaceutically acceptable carrier, including a process for the manufacture of such compositions.Type: ApplicationFiled: March 7, 2003Publication date: November 20, 2003Inventors: Scott Stofik, Robert Gwozdz, Christopher Pelloni, John C. James
-
Patent number: 6627229Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.Type: GrantFiled: June 23, 2001Date of Patent: September 30, 2003Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
-
Patent number: 6616924Abstract: Deer attractant and feed comprising stabilized rice bran and calcium carbonate is disclosed. Limestone is added to the rice during the milling process. The residue from this process, rice bran and a small amount of pulverized limestone, is the cooked in an extruder, resulting in stabilized rice bran. The extrusion process destroys lipase activity and reduces the free fatty acid content to under 4%. The product contains about 12.5% or more protein, and preferably has a 2:1 ratio of calcium to phosphorous. Because of the balanced nutritional analysis and the addition of calcium carbonate to the feed, the product aids in promoting overall deer growth as well as bone growth in bucks. The product also acts as a deer attractant, moving deer toward sources of adequate food supplies and away from cultivated gardens and crops.Type: GrantFiled: June 2, 2000Date of Patent: September 9, 2003Assignee: Producers Rice Mill, Inc.Inventor: Jason N. Chastain
-
Publication number: 20030161894Abstract: Disclosed is a novel form of particulate precipitated aragonite, and a novel process for producing it.Type: ApplicationFiled: September 5, 2001Publication date: August 28, 2003Applicant: 3P TECHNOLOGIES LTD.Inventor: Isaac Yaniv
-
Publication number: 20030157195Abstract: A topical composition and method for the treatment of the symptoms of diaper rashes and skin irritations caused by acidic secretions comprising a) a pH-raising ingredient selected from the group consisting of sodium hydrogen carbonate (bicarbonate of soda), magnesium hydroxide, calcium carbonate, aluminum hydroxide, and mixtures thereof; b) an anhydrous base ointment; c) polysorbate 80; d) a pharmaceutically acceptable diluent; and e) butylated hydroxy toluene, wherein said pharmaceutically acceptable diluent is purified water. The pH of the topical composition is adjusted by adding droplets of glacial acetic acid. The composition can also further comprise AQUAPHOR™. Embodiments disclosed include a cream, dusting powder, spray, bath soak and effervescent tablet, and also the application of the lotion composition to a bodyside diaper liner.Type: ApplicationFiled: February 18, 2003Publication date: August 21, 2003Inventor: Jennifer F. Bartels
-
Patent number: 6602491Abstract: Oral composition comprising: (a) an alkyl hydroxybenzoate represented by formula 1 wherein R represents an alkyl group comprising at least five carbon atoms, and (b) said composition having an alkaline pH.Type: GrantFiled: August 22, 2002Date of Patent: August 5, 2003Assignee: Unilever Home & Personal Care USA, division of Conopco, Inc.Inventors: Peter John Hall, David Thomas Littlewood
-
Publication number: 20030125252Abstract: The invention relates to compositions for promoting and inhibiting osteogenesis and to methods for treating bone abnormalities resulting from injury, toxicity or disease and for ex vivo bone tissue engineering.Type: ApplicationFiled: September 12, 2002Publication date: July 3, 2003Inventors: T. Michael Underhill, Arthur V. Sampaio, Andrea D. Weston
-
Publication number: 20030118665Abstract: Disclosed are far-infrared emission powders and resin-coated steel plates with antibacterial activity and far-infrared emission properties. In addition to being 0.9 or higher in emissivity, the far-infrared emission powders are inhibitory against the growth of bacteria, with a pH value of 7.5-10.5 in its saturate aqueous solution. A coating material comprising 5-100 parts by weight of the powder per 100 parts by weight of a resin is coated to a dry thickness of 5-60 &mgr;m on an electromagnetic shield steel plate without interruption of the intrinsic electromagnetic shield properties of the steel plate.Type: ApplicationFiled: August 16, 2002Publication date: June 26, 2003Inventors: Jae-Young Lee, Eel-Young Kim, Jin-Gun Sohn, Noi-Ha Cho, Ji-Eun Oh, Jae-Eok Cho, Jin-Tae Kim, Jung-Sik Lee, Yong-Min Kim
-
Patent number: 6565891Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.Type: GrantFiled: August 23, 2002Date of Patent: May 20, 2003Assignee: Tsar Health Private Ltd.Inventor: Ranjit Kumar Chandra
-
Patent number: 6562378Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.Type: GrantFiled: August 16, 2002Date of Patent: May 13, 2003Assignee: TSAR Health Private Ltd.Inventor: Renjit Kumar Chandra
-
Patent number: 6558711Abstract: A method for promoting colon health in a subject comprising administering a dose of calcium to the subject that is effective to reduce carcinogenesis. Particularly provided is a method for reducing the risk of recurrence of colorectal adenomas, comprising administering a dose of calcium carbonate effective to promote colon health. In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered once or twice daily resulted in decreased risk of recurrent colorectal adenomas in patients with a history of colorectal adenomas.Type: GrantFiled: August 1, 2002Date of Patent: May 6, 2003Assignee: The Trustees of Dartmouth CollegeInventor: John A. Baron
-
Publication number: 20030068359Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.Type: ApplicationFiled: October 9, 2001Publication date: April 10, 2003Inventor: Martin Kenneth Register
-
Patent number: 6541038Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.Type: GrantFiled: May 25, 2000Date of Patent: April 1, 2003Assignee: SDS Biotech K.K.Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
-
Patent number: 6534097Abstract: A pest deterrent compound includes water, calcium carbonate and hydrogen sulfide. The compound is successful in deterring white flies and other destructive insects from attacking plants. The plant is protected by pouring a liquid solution onto the plant and the ground underneath and around the plant. The compound is absorbed into the plant's leaves and roots and acts as a deterrent against destructive insects. The pest deterrent compound is given in the following formula.Type: GrantFiled: July 11, 2002Date of Patent: March 18, 2003Inventor: Betty Baggott
-
Patent number: 6524558Abstract: The present invention relates to compositions and methods for calcifying dental tissue, e.g., preventing or treating dental hypersensitivity. An oral composition of arginine bicarbonate and calcium carbonate promotes the formation of dentinal tubule plugs aided by combining calcium and phosphate in the fluid. In a specific example, an arginine bicarbonate/calcium carbonate mixture blocked dentinal tubules in a model system. In addition to treating dentinal sensitivity, the compositions and methods of the invention provide for calcifying exposed tooth pulp, calcifying the base or all of a pit or fissure in a tooth, and treating a carious lesion.Type: GrantFiled: August 27, 2001Date of Patent: February 25, 2003Assignee: The Research Foundation of the State University of New YorkInventors: Israel Kleinberg, Ana Marie Acevedo, Robi Chatterjee
-
Publication number: 20030017202Abstract: The present invention provides an oral dosage form for delivering active agents having a soft core with an active agent particles, which have an average size of greater than about 50 &mgr;m, and a brittle shell encasing the soft core, wherein the weight ratio of drug particles to shell being from about 1.0:0.5 to about 1.0:15.Type: ApplicationFiled: June 29, 2001Publication date: January 23, 2003Inventors: Frank J. Bunick, John J. Burke, Timothy P. Gilmor, Michelle Papalini
-
Patent number: 6497902Abstract: Biocompatible hydrogels, for: scaffoldings for tissue engineering; cell encapsulation matrices; injectable bulking materials for cosmetic and functional restorations; controlled release matrices; gene delivery vehicles; immunoprotection matrices; immobilization materials; food additives; medical gels; conductive electrode gels; lubricious coatings; film forming creams; membranes; superabsorbents; hydrophilic coatings; and wound dressings. The hydrogels include: at least one water-soluble polymer/copolymer; and at least one slow and/or fast dissolving and/or releasing divalent and/or multivalent cation-containing compound. At least one of the monomers is an acid, and/or contains an acid group or a derivative thereof. Such monomer reacts with the cations to form a three-dimensional ionically crosslinked hydrogel composition.Type: GrantFiled: December 1, 1999Date of Patent: December 24, 2002Assignee: The Regents of the University of MichiganInventor: Peter X. Ma
-
Publication number: 20020193355Abstract: The therapeutic combination comprises as its associated active ingredients calcium in elemental form and at least one vitamin D. It also contains at least one dry and moist binder combined in synergistic quantity with at least one diluant, at least one binder, and at least one lubricant, at least one of said diluant and said binder being a sweetening agent. Advantageously, the ratio of calcium in elemental form to vitamin D, expressed in mg of elemental Ca per IU of vitamin D lies in the range 1 to 1.5, and preferably in the range 1.2 to 1.3.Type: ApplicationFiled: June 10, 2002Publication date: December 19, 2002Applicant: Laboratoire Innothera, Societe AnonymeInventors: Catherine Meignant, Eric Stenger
-
Patent number: 6488966Abstract: A method for reducing a risk of carcinogenesis in a subject comprising administering a dose of calcium to the subject that is effective to reduce carcinogenesis. Particularly provided is a method for reducing the risk of recurrence of colorectal adenomas, comprising administering a dose of calcium carbonate effective to reduce the risk of colorectal adenomas. In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered twice daily resulted in decreased risk of recurrent colorectal adenomas in patients with a history of colorectal adenomas.Type: GrantFiled: March 27, 2001Date of Patent: December 3, 2002Assignee: The Trustees of Dartmouth CollegeInventor: John A. Baron
-
Publication number: 20020173510Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: April 25, 2002Publication date: November 21, 2002Applicant: DrugTech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Patent number: 6479474Abstract: A method of and composition for diminishing multiple sclerosis symptoms are disclosed. In one embodiment, the method comprises the step of administrating an amount of calcium and a vitamin D compound effect to diminish multiple sclerosis symptoms. In another embodiment, the invention is a pharmaceutical composition comprising an amount of calcium and vitamin D compound effective to diminish multiple sclerosis symptoms.Type: GrantFiled: July 8, 1999Date of Patent: November 12, 2002Assignee: Wisconsin Alumni Research FoundationInventors: Hector F. DeLuca, Margherite T. Cantorna, Jean Humpal-Winter
-
Publication number: 20020155103Abstract: The invention provides a composition which is effective in the prevention or delay of the onset of side effects associated with alcohol consumption or the reduction or alleviation of those effects. The composition of the invention includes activated charcoal and limestone, optionally activated limestone. Optionally, the composition of the invention also includes vitamin B1 and/or other agents such as fatigue relieving agents. Preferably, the composition of the invention is provided in the form of tablets or powder encapsulated in a gelatin capsule. The composition of the invention is provided in pre-dosed quantities varying from between about 100 and 500 milligrams per dose. The invention also provides a method of reducing or alleviating the deleterious effects associated with alcohol consumption.Type: ApplicationFiled: January 11, 2002Publication date: October 24, 2002Inventors: Rymond C. Crippen, Manoj Bhargava, Thomas F. Morse
-
Publication number: 20020150633Abstract: A formulation for reducing a risk of developing hypocalcemia in dairy cattle comprises beet pulp, brewers grains or distillers grains, high temperature treated soybean meal having a protein dispersability index (PDI) of less than 10; hydrochloric acid; feed grade calcium carbonate and buffering compounds.Type: ApplicationFiled: March 11, 2002Publication date: October 17, 2002Inventors: Myron Danzer, James Henry, Phillip Jardon
-
Patent number: 6451354Abstract: A salt-spice-herbal composition known as Amrita Bindu that is clinically useful for reducing IgE production and treating secondary allergic responses is disclosed.Type: GrantFiled: October 25, 2000Date of Patent: September 17, 2002Assignee: Pharma Terra, Inc.Inventors: Rolland Hebert, Edayatimangalam Raja Bhavani Shanmugasundaram, Kalathkal Radha Shanmugasundaram
-
Patent number: 6447809Abstract: A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.Type: GrantFiled: May 11, 2000Date of Patent: September 10, 2002Assignee: Metagenics, Inc.Inventors: Kim C. Krumhar, Holly A. Johnson
-
Patent number: 6436370Abstract: The present invention relates to compositions and methods for calcifying dental tissue, e.g., preventing or treating dental hypersensitivity. An oral composition of arginine bicarbonate and calcium carbonate promotes the formation of dentinal tubule plugs aided by combining calcium and phosphate in the fluid. In a specific example, an arginine bicarbonate/calcium carbonate mixture blocked dentinal tubules in a model system. In addition to treating dentinal sensitivity, the compositions and methods of the invention provide for calcifying exposed tooth pulp, calcifying the base or all of a pit or fissure in a tooth, and treating a carious lesion.Type: GrantFiled: February 15, 2000Date of Patent: August 20, 2002Assignee: The Research Foundation of State University of New YorkInventors: Israel Kleinberg, Ana Marie Acevedo, Robi Chatterjee
-
Patent number: 6416790Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: March 13, 2000Date of Patent: July 9, 2002Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6417166Abstract: A strong, thin flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin mineralized collagen membrane has a bulk density of the membrane of at least about 1.0 g/cm3 and has a thickness not greater than about 0.5 mm and preferably not greater than about 0.3 mm.Type: GrantFiled: May 19, 2001Date of Patent: July 9, 2002Assignee: Ceramedical, Inc.Inventor: Sung-Tsuen Liu
-
Patent number: 6407038Abstract: A method for controlling Tylenchid plant-parasitic nematodes through application of an effective amount of an alkaline-stabilized sludge is described. In accordance with particular embodiments, the alkaline-stabilized sludge may be applied to the plant, seed or locus thereof.Type: GrantFiled: June 16, 2000Date of Patent: June 18, 2002Assignee: Her Majesty the Queen in right of Canada, as represented by c/o Minister of Agriculture and Agri-Food CanadaInventors: Thomas William Welacky, Edward Topp
-
Patent number: 6395301Abstract: An anhydrous hydrophobic cosmetic composition in the form of a compact powder which can be taken up in dry form or with water, comprising a particulate phase comprising hydrophilic pulverulent compounds, wherein the hydrophilic pulverulent compounds represent 20 to 35% by weight relative to the total weight of the particulate phase. The invention also relates to a make-up process using such a composition, as well as to a device comprising such a composition and a sponge which can be moistened.Type: GrantFiled: December 30, 1999Date of Patent: May 28, 2002Assignee: L'OréalInventor: Hervé Cantin
-
Patent number: 6384087Abstract: The subject invention provides methods of inducing the loss of adipose tissue by providing a diet high in calcium. In one aspect of the invention, the calcium is provided in the form of dairy products. In yet another aspect of the invention, calcium is provided in the form of a dietary supplement, such as calcium carbonate, of vitamin supplements. Methods of suppressing [Ca2+]i levels in individuals are also provided. The subject invention also provides methods of stimulating lipolysis, inhibiting lipogenesis, and increasing the expression of white adipose tissue uncoupling protein 2 (UCP2). The subject invention also provides methods of increasing the core temperature of an individual.Type: GrantFiled: September 1, 2000Date of Patent: May 7, 2002Assignee: University of Tennesseee Research Corporation, Inc.Inventors: Michael B. Zemel, Hang Shi, Paula C. Zemel
-
Publication number: 20020044974Abstract: A process for producing granular calcium carbonate for use as dietary supplements and/or antacids, which easily reconstitutes, upon mixing with a liquid or liquid-containing food prior to ingestion, into an ultra-fine calcium carbonate powder having improved non-gritty “mouthfeel”. The process involves aggregating an ultra-fine calcium carbonate powder, having an average particle size of no more than 25 microns, into granular calcium carbonate particles. Methods for administering 100% of the adult RDA for calcium in a single dose, and for treating upper gastrointestinal tract disorders, using the granular calcium carbonate produced by the process of the present invention are also disclosed.Type: ApplicationFiled: September 7, 2001Publication date: April 18, 2002Inventor: Alexander R. Malcolm
-
Patent number: 6368638Abstract: The present invention relates to a high dosage calcium carbonate aqueous antacid pharmaceutical suspension for oral use, and methods of preparation.Type: GrantFiled: September 7, 2000Date of Patent: April 9, 2002Assignee: SmithKline Beecham CorporationInventor: Antonio Tiongson
-
Patent number: 6355278Abstract: A formulation for preventing or treating parturient hypocalcemia or milk fever comprises a solution of hydrochloric acid in water, soybean meal, additional feed components and minerals. The feed formulation is prepared by grinding soybean meal to a particle size of 1000 to 2000 microns. A hydrochloric acid solution and feedgrade limestone are blended into the meal to produce the formulation.Type: GrantFiled: March 31, 1999Date of Patent: March 12, 2002Assignee: West Central CooperativeInventors: William D. Stidham, Donald W. Seaman, Myron F. Danzer, James P. Henry
-
Patent number: 6322821Abstract: A composition for preventing and treating milk fever in freshening cows, and a method of administering the composition. The basic composition is a mixture of water, calcium chloride, propylene glycol, B vitamins and minerals. The calcium content is lower than conventional calcium treatments used for this purpose. The propylene glycol gives the cow an energy boost and sweetens the taste so the cow does not object to it as it does to conventional gels and liquids. The B vitamins stimulate the cow's appetite. The minerals replace minerals lost in the milk and also help the cow absorb calcium. The composition of the present invention is in a liquid form and is preferably administered using a 200-300 cc drench gun. The end of the dispensing tube of the drench gun is placed between the teeth and cheek of the cow near the receptors that stimulate the esophageal groove reflex.Type: GrantFiled: September 27, 1999Date of Patent: November 27, 2001Inventor: Jack W. Register
-
Publication number: 20010043953Abstract: An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the animal such as clamshell, eggshell, crustacean shell, bone, coral, and pearl, and calcium carbonate-containing minerals such as limestone. When a temperature of the heat treatment is not less than 650° C. and less than a melting point of the calcium component-containing substance, a sufficient time of the heat treatment is 2 to 13 hours.Type: ApplicationFiled: June 23, 2001Publication date: November 22, 2001Inventors: Kazutomo Kikuchi, Noriaki Kikuchi
-
Patent number: 6300315Abstract: A thin, strong, flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin, strong, flexible mineralized collagen membrane has a bulk density of at least about 1.0 g/cm3.Type: GrantFiled: August 28, 1999Date of Patent: October 9, 2001Assignee: Ceramedical, Inc.Inventor: Sung-Tsuen Liu
-
Patent number: 6287548Abstract: The present invention provides a composition of matter which has been demonstrated to be a very effective treatment for acne, seborrheic dermatitis and related skin diseases when applied to and contacted with affected skin areas, while avoiding the disadvantages and complications attendant to more established treatments. The composition comprises a synthetic mixture of salts which, when dissolved in a solvent such as water, is ionically composed primarily of a mixture of sodium and magnesium cations and chloride and sulfate anions, and which is preferably free of added zinc. More specifically, the salt mixture according to the present invention comprises the following range of composition in grams/kilogram of salt mixture in the ionic state, the balance being water of hydration: I.Type: GrantFiled: November 21, 1994Date of Patent: September 11, 2001Assignee: Bio.Life International AGInventor: Hans F. Biener
-
Patent number: 6287607Abstract: A composition useful as a dietary supplement for providing potassium, calcium, and citrate is presented, as well as processes for producing the composition, and methods for using the composition as a dietary supplement. Administration of the composition counters bone loss associated with aging or menopause by providing bioavailable calcium and, simultaneously, delivering alkali load. In addition, administration of the composition produces a substantial increase in urinary citrate, which counters kidney-stone formation.Type: GrantFiled: July 19, 1999Date of Patent: September 11, 2001Assignees: Mission Pharmacal Company, Board of Regents, University of Texas SystemInventors: Charles Y. C. Pak, George Alexandrides, Neill B. Walsdorf